162 related articles for article (PubMed ID: 1702912)
1. Hepatotrophic effects of FK506 in dogs.
Starzl TE; Porter KA; Mazzaferro V; Todo S; Fung J; Francavilla A
Transplantation; 1991 Jan; 51(1):67-70. PubMed ID: 1702912
[TBL] [Abstract][Full Text] [Related]
2. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth.
Iwabuchi T; Maruyama T; Sei Y; Adachi K
J Dermatol Sci; 1995 Jan; 9(1):64-9. PubMed ID: 7537082
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
Schreiber SL
Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
[TBL] [Abstract][Full Text] [Related]
4. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
Harding MW; Galat A; Uehling DE; Schreiber SL
Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
Zarnt T; Lang K; Burtscher H; Fischer G
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional features of the peptidyl prolyl cis-trans isomerase, cyclophilin.
Harding MW
Pharmacotherapy; 1991; 11(6):142S-148S. PubMed ID: 1771139
[No Abstract] [Full Text] [Related]
7. When worlds collide: immunosuppressants meet protein phosphatases.
McKeon F
Cell; 1991 Sep; 66(5):823-6. PubMed ID: 1716181
[No Abstract] [Full Text] [Related]
8. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.
Rosen MK; Standaert RF; Galat A; Nakatsuka M; Schreiber SL
Science; 1990 May; 248(4957):863-6. PubMed ID: 1693013
[TBL] [Abstract][Full Text] [Related]
10. Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks?
High KP; Handschumacher RE
Infect Agents Dis; 1992 Jun; 1(3):121-35. PubMed ID: 1285413
[TBL] [Abstract][Full Text] [Related]
11. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin.
Maki N; Sekiguchi F; Nishimaki J; Miwa K; Hayano T; Takahashi N; Suzuki M
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5440-3. PubMed ID: 1695378
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
Schreier MH; Baumann G; Zenke G
Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
[No Abstract] [Full Text] [Related]
13. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
[No Abstract] [Full Text] [Related]
14. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
Kay JE
Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
[No Abstract] [Full Text] [Related]
15. Peptidyl-prolyl cis-trans isomerase from Bacillus subtilis. A prokaryotic enzyme that is highly sensitive to cyclosporin A.
Herrler M; Bang H; Brune K; Fischer G; Marahiel MA
FEBS Lett; 1992 Sep; 309(3):231-4. PubMed ID: 1516692
[TBL] [Abstract][Full Text] [Related]
16. Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding.
Tropschug M; Wachter E; Mayer S; Schönbrunner ER; Schmid FX
Nature; 1990 Aug; 346(6285):674-7. PubMed ID: 1696687
[TBL] [Abstract][Full Text] [Related]
17. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
[TBL] [Abstract][Full Text] [Related]
18. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands.
Yu L; Fesik SW
Biochim Biophys Acta; 1994 Nov; 1209(1):24-32. PubMed ID: 7524680
[TBL] [Abstract][Full Text] [Related]
19. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin.
Griffiths EJ; Halestrap AP
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):611-4. PubMed ID: 1706598
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
Bierer BE
Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
